BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
228 Results
Year
Month
Day
  • The global Urokinase market size is estimated to be worth US$ 45 million in 2021 and is forecast to a readjusted size of US$ 64 million by 2028 with a CAGR of 5.2% during the forecast period 2022-2030.
  • The global Age Related Macular Degeneration Drug market size is estimated to be worth US$ 7725.7 million in 2021 and is forecast to a readjusted size of US$ 11590 million by 2028 with a CAGR of 5.9% during the forecast period 2022-2030.
  • The global Cancer Treatment Drugs market size is estimated to be worth US$ 178880 million in 2021 and is forecast to a readjusted size of US$ 325040 million by 2028 with a CAGR of 8.8% during the forecast period 2022-2030.
  • The global Flu Vaccine market size is estimated to be worth US$ 5505 million in 2021 and is forecast to a readjusted size of US$ 7673.2 million by 2028 with a CAGR of 4.8% during the forecast period 2022-2030.
  • The global Glucagon market size is estimated to be worth US$ 556 million in 2021 and is forecast to a readjusted size of US$ 845.7 million by 2028 with a CAGR of 6.1% during the forecast period 2022-2030.
  • The global Transdermal Patch market size is estimated to be worth US$ 6793 million in 2021 and is forecast to a readjusted size of US$ 8726.9 million by 2028 with a CAGR of 3.6% during the forecast period 2022-2030.
  • The global Rabies Vaccine market size is estimated to be worth US$ 931 million in 2021 and is forecast to a readjusted size of US$ 1229.1 million by 2028 with a CAGR of 4.0% during the forecast period 2022-2030.
  • The global Newcastle Disease Vaccine market size is estimated to be worth US$ 314.8 million in 2021 and is forecast to a readjusted size of US$ 396.2 million by 2028 with a CAGR of 3.3% during the forecast period 2022-2030.
  • The global Metronidazole market size is estimated to be worth US$ 113 million in 2021 and is forecast to a readjusted size of US$ 109.1 million by 2028 with a CAGR of -0.5% during the forecast period 2022-2030.
  • The global Low Trauma & Skin Friendly Adhesives market size is estimated to be worth US$ 93 million in 2021 and is forecast to a readjusted size of US$ 120.3 million by 2028 with a CAGR of 3.7% during the forecast period 2022-2030.